SCHEMBL6582812

SCHEMBL6582812

CC(C)(C)OC(=O)N1CCC(NC(=O)Nc2cccc(C#N)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA9 Q16790 1/20 0.56
USP30 Q70CQ3 1/20 0.54
EPHX1 P07099 1/20 0.52
CCNC P24863 1/20 0.51
CDK8 P49336 1/20 0.51
EPHX2 P34913 7/20 0.51
SIRT2 Q8IXJ6 1/20 0.50
SIRT1 Q96EB6 1/20 0.50
CYP2D6 P10635 1/20 0.50
HSD17B10 Q99714 1/20 0.50
GPR119 Q8TDV5 3/20 0.48
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.46
MAPT P10636 1/20 0.46
KMT2A Q03164 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377671 0.87 ALDH1A1 (0.58) CYP2D6HSD17B10GPR119ALDH1A1MAPT
SCHEMBL30732878 0.85 SIRT2 (0.52) USP30CCNCCDK8EPHX2SIRT2
SCHEMBL17296358 0.85 BRD4 (0.57) USP30CYP2D6HSD17B10
SCHEMBL5001323 0.84 EPHX2 (0.68) CA12CA1CA2CA9USP30
SCHEMBL331606 0.83 ALDH1A1 (0.51) USP30CYP2D6HSD17B10GPR119ALDH1A1
SCHEMBL331605 0.83 ALDH1A1 (0.51) USP30CYP2D6HSD17B10GPR119ALDH1A1
SCHEMBL14834005 0.83 EPHX2 (0.51) USP30EPHX1CCNCCDK8EPHX2
SCHEMBL7423886 0.83 EPHX2 (0.52) CCNCCDK8EPHX2CYP2D6HSD17B10
SCHEMBL14072821 0.82 EPHX2 (0.75) CA12CA1CA2CA9USP30
SCHEMBL6583644 0.81 CYP2D6 (0.48) USP30EPHX2SIRT2SIRT1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0960104-B1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL MYERS SQUIBB PHARMA CO (US) 2004-06-16 EP disclosed
US-6521614-B1 Anticoagulant agents for treatment and prevention of thromboembolic disorders BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-02-18 US disclosed
EP-0960104-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 1999-12-01 EP disclosed
US-5925635-A 2-(OXO-1,3-PERHYDRODIAZEPINES OR 3-OXO-2,3,4,5-TETRAHYDRO-1H-2,4-BENZODIAZEPINES; ANTICOAGULANTS; ENZYME INHIBITORS OF SERINE PROTEASE THROMBIN, KALLIKREIN AND PLASMIN; NERVOUS SYSTEM DISORDERS; ANTIINFLAMMATORY AGENTS DUPONT PHARMACEUTICALS COMPANY (US) 1999-07-20 US disclosed
WO-1997038984-A1 N-(AMIDINOPHENYL)-N'-(SUBST.)-3H-2,4-BENZODIAZEPIN-3-ONE DERIVATIVES AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1997-10-23 WO disclosed